Jangus B. Whitner

ORCID: 0000-0003-0443-4132
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmaceutical Practices and Patient Outcomes
  • Patient Safety and Medication Errors
  • Pediatric health and respiratory diseases
  • Diabetes Management and Research
  • Innovations in Medical Education
  • Mobile Health and mHealth Applications
  • Asthma and respiratory diseases
  • Smoking Behavior and Cessation
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Medical Education and Admissions
  • Patient Satisfaction in Healthcare
  • Inflammatory mediators and NSAID effects
  • Health Literacy and Information Accessibility
  • Vitamin D Research Studies
  • Athletic Training and Education
  • Medication Adherence and Compliance
  • Vitamin C and Antioxidants Research
  • Pharmacovigilance and Adverse Drug Reactions
  • Heart Failure Treatment and Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Healthcare cost, quality, practices

Primary Health Care
2023

KentuckyOne Health
2019

ProMedica Toledo Hospital
2015

University of Toledo
2015

Abstract: Federally qualified health centers (FQHCs) are safety-net institutions that heavily affected by burnout among care professionals. We examined pharmacist-clinician relationships in FQHCs assessing clinicians' satisfaction with clinical pharmacy services (CPS), perceptions of the impact CPS on patient and clinician well-being, potential retention. used a survey composed 21 questions sent to clinicians practicing within Ohio-based access CPS. Respondents noted positively their...

10.1353/hpu.2025.a959107 article EN Journal of Health Care for the Poor and Underserved 2025-05-01

In October 2012, a pharmacy-driven Inpatient Diabetes Patient Education (IDPE) program was implemented at the University of Toledo Medical Center (UTMC).To determine difference in 30-day hospital readmission rates for patients who receive IDPE compared to those do not.This retrospective cohort completed UTMC. Patients admitted between 1, and September 30, 2013, were included if they ≥18 years had one following: (1) diagnosis diabetes mellitus, (2) blood glucose >200 mg/dL (>11.11 mmol/L) on...

10.1177/0897190019833217 article EN Journal of Pharmacy Practice 2019-02-27

Objectives: The primary objective of this study is to determine the effect proactive pharmacist identification high-risk patients eligible for diagnostic spirometry testing on percentage appropriate referrals ordered and tests completed in those that qualify. Methods: This prospective compares between an intervention site control within a federally qualified health center (FQHC) where pharmacists provide services. At both sites, all who had care provider (PCP) appointment screening...

10.1177/2150132719889715 article EN cc-by-nc Journal of Primary Care & Community Health 2019-01-01

Background and Objectives: Nonsteroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly used pain medications among US adults with about 70 million people regularly taking NSAIDs annually. Despite clear recommendations from current clinical practice guidelines recent supporting literature, continually prescribed inappropriately in patients chronic kidney disease (CKD), hypertension (HTN), heart failure (HF). The purpose this project was to determine impact direct pharmacist-led...

10.22454/fammed.2020.147410 article EN Family Medicine 2020-09-02

Type: Letter

10.24926/iip.v6i4.401 article EN cc-by-nc INNOVATIONS in pharmacy 2015-01-01

Background: The 340B Drug Pricing Program provides discounted drug prices to safety-net entities which help stretch scarce resources expand comprehensive services and treat more vulnerable patients. program has received criticism questioning whether the original intentions are being accomplished. Objective: This qualitative study aimed understand lived experiences of patients accessing high-cost injectable diabetes medication(s) through a Prescription Cash Discount (PCDP) provided at...

10.24926/iip.v14i3.5445 article EN cc-by-nc INNOVATIONS in pharmacy 2023-10-02
Coming Soon ...